Events picture

Clinical Grand Rounds March 21, 2014, 12:00 pm - 1:30 pm WPIC Auditorium

Bridging the Mortality Gap for People with Psychotic Illnesses:  An Exploration of Decreased Life
Expectancy in Schizophrenia Due to Cardiovascular Disease, and a Review of Evidence Based
Primary and Secondary Prevention

 


Clinical Grand Rounds

Comprehensive Recovery Service

Presented by

Jessica Gannon, MD
Assistant Professor of Psychiatry 
University of Pittsburgh School of Medicine 

Moderator:  

Rohan Ganguli, MD, FRCP(C) 
Professor of Psychiatry and Canada Research Chair
Adjunct Professor, Dalla Lana School of Public Health
University of Toronto
Senior Scientist, Center for Addiction and Mental Health (CAMH)
Adjunct Professor of Psychiatry
University of Pittsburgh School of Medicine

Individuals with schizophrenia, schizoaffective disorder and other psychotic disorders continue to die of largely preventable causes at ages much younger than the general population.   This alarming statistic has not changed much over time, but in recent decades, cardiovascular disease has emerged as chief among the “natural causes” of death for this patient population.  Risks factors for developing cardiovascular disease, some of which may be particular to this population, will be discussed, as will evidence based efforts at monitoring for these risk factors.  Current evidence based interventions at both preventing and treating cardiometabolic risk factors, particularly related to weight gain and decreased physical activity, will be introduced.  Finally, future directions at preventing cardiovascular disease in persons with schizophrenia spectrum disorders will be explored.  

Learning Objectives:  At the conclusion of the lecture, participants will be able to:

  1. Review life expectancy in schizophrenia and common “natural causes” of death in this patient population.
  2. Define metabolic syndrome and recall common cardiometabolic risk factors in  individuals with schizophrenia.
  3. Discuss current and future directions in primary and secondary interventions of cardiovascular disease in persons with schizophrenia.

Sponsored by Western Psychiatric Institute and Clinic
the Office of Clinical Affairs of WPIC and
the Department of Psychiatry
University of Pittsburgh School of Medicine

All are welcome to attend.

Continuing Education Credit: The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Pittsburgh School of Medicine designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits TM. Each physician should only claim credit commensurate with the extent of their participation in the activity. Other health care professionals are awarded .15 continuing education units (CEUs), which are equal to 1.5 contact hours. In accordance with Accreditation Council for Continuing Medical Education requirements on disclosure, information about relationships of presenters with commercial interests (if any) will be included in materials which will be distributed at the time of the conference.  WPIC is approved by the American Psychological Association to offer continuing education for psychologists.  WPIC maintains responsibility for this program and its contents.  This program is being offered for 1.5 continuing education credits.

Please indicate any personal accommodations you may need for this Clinical Grand Round such as sign language interpreter, large print conference materials, Braille Conference materials, accessible parking.  Please contact Ann 412-246-6608 before the Clinical Grand Round should you need accommodations.

Faculty Disclosure:  In accordance with Accreditation Council for Continuing Medical Education requirements on disclosure, information about relationships of presenters with commercial interests (if any) will be included in materials available at the time of the conference.